While Regencell Bioscience Holdings Ltd has overperformed by 30.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RGC rose by 689.52%, with highs and lows ranging from $45.73 to $3.03, whereas the simple moving average jumped by 791.02% in the last 200 days.
Analysis of Regencell Bioscience Holdings Ltd (RGC)
One of the most important indicators of Regencell Bioscience Holdings Ltd’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -42.49% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 41.92, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and RGC is recording 639.13K average volume. On a monthly basis, the volatility of the stock is set at 32.94%, whereas on a weekly basis, it is put at 52.72%, with a gain of 364.58% over the past seven days.
How Do You Analyze Regencell Bioscience Holdings Ltd Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 93.84%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 0.24% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RGC shares are owned by institutional investors to the tune of 0.24% at present.
